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ABSTRACT 
Histone modification is the form of epigenetic control, which is quite complex and diverse. The 
regulation of gene expression and the balance of histone acetylation and deacetylation is an 
epigenetic layer can be maintained by the post translational modifications of core histones. 
Histone acetylation is an important mechanism for the control of eukaryotic transcription. 
Acccumulated evidence shows that aberrant regulation of histone deacetylase is one of the major 
causes of development of human malignancies.HDAC modulates gene expression by chromatin 
remodelling during malignant transformation and represses transcription by deacetylating 
histone.  Altered expression and mutations of genes that encodes HDACs have been linked to 
tumor development since they both induce aberrant transcription of key genes regulating 
important cellular functions such as cell proliferation, cell-cycle regulation and apoptosis. 
Among different isoenzymes of HDAC, how HDAC1 is causing carcinogenesis in solid tumors 
is little unknown. The aim of this study was to check the expression of HDAC1 for the regulation 
of malignant behavior in lymph node cancer cell.HDAC1 showed expression in the cancer cell 
indicating the involvement of HDAC1 in the inactivation of certain genes playing role in lymph 
node metastasis.  
Key words: histone modification, HDAC, chromatin remodeling, isoenzymes , malignancies. 
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1. INTRODUCTION 
Histone deacetylases are the class of enzymes which are involved in various 
epigenetic mechanisms. The history of epigenetics is linked with the study of evolution 
and development. But during the past 50 years, the meaning of the term "epigenetics" has 
itself undergone an evolution that parallels our dramatically increased under-standing of 
the molecular mechanisms underlying regulation of gene expression in eukaryotes. The 
word epigenetics can be defined as "the study of changes in phenotype   that can not be 
explained by changes in DNA sequence" (Riggs et al., 1996). Until the 1950s, however 
the word epigenetics was used in an entirely different way to categorize all of the 
developmental events leading from the fertilized zygote to the mature organism-that is, 
all of the regulated processes that, beginning with the genetic material, shape to the final 
product (Waddington, 1953). In other words epigenetics change influence the phenotype 
without changing the genotype as shown in fig: 1. 
 
     Fig.1: General description about epigenetics (adapted from               
Epigenetics by C.David Allis) 
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C.H Waddington in 1942 coined the term Epigenetics as a portmanteau of the 
words genetics and epigenesist .It is an old word ,more recently been used  to describe the 
differentiation of cells in embryonic development  from their initial totipotent  state. The 
usage of the word in scientific discourse is more narrow , that refers to heritable traits 
(over rounds of cell division and sometimes transgenerationally) that do not involve 
changes in  DNA sequence
 
.The Greek word “epi” represents that epigenetic traits exist 
on top of or in addition to the traditional molecular basis for inheritance. 
This word is having similarity with the word "genetics" that has generated many 
parallel usages. The word "epigenome" is a parallel to the word “genome” and it refers to 
the epigenetic state of a cell in whole. The phrase "genetic code" has also been adapted 
the "epigenetic code" has been used to describe the set of epigenetic features that create 
different phenotypes in different cells. The "epigenetic code" could represent the total 
state of the cell, with the position of each molecule accounted through a  a diagrammatic 
representation of the gene expression i.e., epigenomic map. 
1.1 EPIGENETIC PROCESSES 
The various epigenetics processes are mainly 
 DNA methylation 
 Histone modification 
 RNA interference 
The psychologist Erik Erikson used the term epigenetics in his theory of 
psychosocial development. That usage, however, is of primarily historical interest. 
1.2 MOLECULAR BASIS OF EPIGETICS 
The molecular basis of epigenetics is complex that involves modifications of the 
activation of certain genes, but do not involve in changing the basic structure of DNA. In 
addition to this, the chromatin proteins associated with DNA may be activated or 
silenced. This is the reason why the differentiated cells in a multi-cellular organism 
express only the genes which are necessary for their own activity. When cells divide, they 
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preserve epigenetic changes. Within the course of one individual organism's lifetime 
most epigenetic changes tries to express themselves, but, if a mutation in the DNA has 
been caused in sperm or egg cell that results in fertilization, then some epigenetic 
changes are inherited from one generation to the next. The question arises here is of 
whether or not the alteration of the basic structure of its DNA is due to epigenetic 
changes in an organism - Lamarckism.  
1.3 EPIGENETIC EFFECT IN HUMANS 
 Genomic imprinting and related disorders 
The phenomenon in mammals in which both father and mother contribute 
different epigenetic patterns for specific genomic loci in their germ cells,is named 
as genomic imprinting. The various disorders associated with genomic imprinting 
are: Angelman syndrome, Prader willi syndrome, Beckwith-wiedemann 
syndrome. 
 Transgenerational epigenetic observations 
 Cancer and developmental abnormalities 
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1.5 HISTONE DEACETYLASES (HDACs) 
Classes of enzymes that remove acetyl groups from an ε-N-acetyl lysine amino acid on a 
histone are Histone deacetylases (HDAC). Histone acetyltransferase acts opposite to 
that of HDAC proteins that are now also being referred to as lysine deacetylases 
(KDAC). The balance between the opposing activities of histone acetyl transferases and 
histone deacetylases (HDACs) results steady-state levels of acetylation of the core 
histones. Increased transcriptional activity is due to increased levels of histone acetylation 
(hyperacetylation), whereas decreased levels of acetylation(hypoacetylation) are 
associated with repression of gene expression. 
        1.6 GENERAL OVERVIEW 
  Classification 
Based on function and DNA sequence similarity can be categorized into four 
groups . Trychostatin A (TSA) is a HDAC inhibitor but it does not shows any effect on 
classII HDACs which belongs to a, family of NAD+-dependent proteins. Reduced 
potassium dependency 3 (Rpd3), that corresponds to Class I- histone deacetylase1 (hda1), 
Class II- and silent information regulator 2 (Sir2), Class III are three groups which are 
homologues to these proteins and are found in Yeast. The fourth group is considered an a 
typical category of its own, based solely on DNA sequence similarity to the others. 
HDAC 1, 2, and 8 are found primarily in the nucleus that will be included under Class I 
HDACs,  whereas HDAC 3 is membrane-associated i.e, found in both the nucleus and the 
cytoplasm .ClassII HDACs (HDAC 4, 5, 6, 7, 9 and 10) share domains with similarity to 
HDAC1,another deacetylase found in yeast. A new member of the HDAC family has 
been identified recently,. All the necessary features for this HDAC11 to be designated as 
a HDAC are found to be present in it. (Annemieke et al., 2003). 
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Localization  
 
 HDACs should be in the nucleus, where their predominant substrate is found to 
exert their function. The nuclear localization of HDACs is triggered by the nuclear 
localization signal (NLS) or via co-localization together with other proteins. The 
localization of HDAC1 and HDAC2 is exclusively nuclear due to the lack of a nuclear 
export signal (NES). However, HDAC3 has both a NES and a nuclear import signal, 
suggesting that HDAC3 can also localize to the cytoplasm. Class II HDACs (HDAC 4, 5, 
6, 7, 9, and 10) can shuttle in and out of the nucleus depending on different signals. 
HDAC 6 is a cytoplasmic, microtubule -associated enzyme which deacetylates tubulin, 
Hsp90, and cortactin, and forms complexes with other partner proteins, and is, therefore, 
involved in a variety of biological processes. 
 
Revolutionary relationship between the HDAC 
 
 Evolutionarily, the classes I HDACs are related to yeast RPD3 and the class II 
HDACs are related to the yeast HDAC enzyme. 
 RPD3 is most related to HDAC1 and HDAC2; HDAC1is most closely related to 
HDAC6.  
 From the phylogenetic tree, it can be concluded that HDAC9a, HDAC9b and 
HDAC9c/HDRP form a distinct group with in classII that seem to be less related to 
the members of class II.  
 HDAC11has been placed in other class because it has not shown enough identity with 
classI or classII HDACs. 
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Fig. 2: Localization of different HDACs in which the nucleus is depicted in blue.14-3-3 
protein (red) can retain HDAC4/5 orHDAC7 in the cytoplasm when they are phosphorylated 
(Annemieke et al., 2003). CaMK (green) is involved in nuclear export via the calcium/calmodul 
in signalling pathway. Subcellular localization of (A) classIHDACs and (B) classII HDACs are  
shown,(C) Shuttling of HDAC4,HDACs5 and HDACs7 during muscle diﬀerentiation . 
7  
 
1.7 MECHANISM OF ACTION 
HDAC enzymes remove the acetyl group from the histones. The space between 
the nucleosome and DNA is decreased due to hypo acetylation and the DNA is compactly 
wrapped around it. The  accessibility of transcription factors is decreased by tighter 
wrapping of the DNA which leads to transcriptional repression, as given in figure 1.The 
catalytic domain of HDAC is formed by a stretch of approximately 390 amino acids 
consisting of a set of conserved aminoacids.The active site consists of a gently curved 
tubular pocket with a wider bottom. Removal of an acetyl group occurs via a charge relay 
system consisting of two adjacent histidine residues, two aspartic residues (located 
approximately 30amino acids from the histidines and separated by approximately 6 
aminoacids) and one tyrosine residue (located approximately 123aminoacids downstream 
from the aspartic residues). An essential component of this charge-relay system is the 
presence of a Zn
+ +
 ion as shown in fig. 3 and 4. This atom is bound to the zinc binding 
site on the bottom of the pocket. Other co-factors are required for HDAC activity. HDAC 
functions by displacing the zinc ion and thereby making the charge-relay system 
dysfunctional. TSA is the most potent reversible HDACi currently known, with an IC50 in 
low nano molar range. TSA, with its hydroxamic acid group and its five-carbon atom 
linker to the phenyl group, has the optimal conformation to fit into the active site. 
                                           
Fig. 3: Zinc dependent HDAC 
 
 
Fig.4:HAT AND HDAC ACTIVITY 
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1.8 HDAC INHIBITOR (HDACi) 
Recent studies shows that HDACi inhibits HDAC by blocking the access of 
HDAC to the active site (reversible or irreversible).There is many inhibitors but most 
potent discovered so far are Trychostatin (TSA) which is a fermentation product of 
Streptomyces. Originally TSA was used as an anti-fungal agent, but later it was 
discovered to have potent proliferation inhibitory properties with cancer cells. 
 
                                                                                                         
 
 
 
 
 
 
   Fig. 5: Activity of HDAC inhibitors 
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2. REVIEW OF LITERATURE 
2.1 Role of HDAC and N-CoR in sin3 mediated transcriptional repression 
sin3 can function as a transcriptional repressor without involving any chromatin 
regulators. The activity of component are convincing of the basal transcriptional 
machinery are affected by the sin3 associated proteins. The function of sin3 as a repressor 
is known because findings show that transcriptional activation of some genes is reduced 
in case of sin3 null mutants. The interaction between msin3 and N-CoR mediate the 
transcriptional silencing by nuclear hormone receptor. Myc activities require interaction 
with mammalian sin3a and sin3b protein for mediating Mxi1- inhibition, which have 
been proposed to act as scaffolds for additional co-repressor factors. The identification of 
two such sin-3 associated factors, the nuclear receptor co-repressor (NCo-R) and histone 
deacetylase (HDAC1), provides a basis for Mxi1/sin3 induced transcriptional repression 
and tumor suppression. 
Transcriptional repression by msin3A and msin3B 
Studies shown that when mammalian protein msin3Blf and msin3Bsf were fused 
to GAL4 DNA binding domain (GAL4), it can repress the basal transcription of a 
chloramphenicol acetyl transferase which bears five GAL4 DNA binding sites upstream 
either major late promoter (MLP) or thymidine kinase promoter (TK).When the regions 
of  msin3A containing only PAH1 and PAH2 (paired amphipathic helical) were fused to 
GAL4 domain similar results were obtained. 
HDAC1 interact with msin3Blf but not with msinBsf: 
It has been suggested that the C- terminal region of PAH2 is integral to tumor 
suppression mediated by msin3B. From the genetic analysis of yeast it has been found 
that the link between histone acetylation factors and tumor prone conditions shows a tight 
functional relationship between sin3 and RPD3 (a yeast homologue of the human histone 
deacetylase HDAC1). When low-stringency co-immunoprecipitation was done between 
HDAC1 and msin3B to know whether there is any physical interaction between these two 
in mammalian cell, it has been found that the long form of msin3B(PAH3+4) possesses 
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potent anti-oncogenic activity and is sufficient for the interaction between HDAC1 and 
msin3B when linked directly to Mxi1 (Alland et al., 1997). 
2.2 Role of HDACs in cancer (Santiago Ropero,Manel Esteller,2007) 
 Deregulation of DNA methylation and posttranslational histone modiﬁcation, especially 
histone acetylation is a typical characteristic of human cancer with fatal consequences 
such as that of gene transcription-deregulation. 
 Data studies from a panel of normal tissues, primary tumors and human cancer cell lines 
indicate that a loss of acetylated Lys16 (K16-H4) and tri-methylated Lys20 (K20-H4) of 
histone H4 is a common event in human cancer associated with hypomethylation of 
repetitive sequences. 
 A study of gastro intestinal tumors concluded that the decrease in histone acetylation is 
not only involved in initiation of tumor genesis but also in tumor invasion and metastasis.  
 Although there are no conclusive data about the pattern of HDAC expression in human 
cancer, there are a number of studies showing altered expression of individual HDACs in 
tumor samples. 
 An increase in HDAC1expression in gastric, prostate, colon, and breast carcinomas. 
 Over expression of HDAC2 has been found in cervical, and gastric cancers, and in 
colorectal carcinoma with loss of APC expression. 
 Other studies have reported high levels of HDAC3 and HDAC6 expression in colon and 
breast cancer specimens, respectively. 
 Different findings suggest that the transcriptional repression of tumor suppressor genes 
by over expression and aberrant recruitment of HDACs to their promoter region could be 
a common phenomenon in tumor onset and progression. 
 The cyclin-dependent kinase inhibitor p21WAF inhibits cell-cycle progression and whose 
expression is lost in many different tumors. 
 In some tumors, p21WAF1 is epigenetically inactivated by hypoacetylation of the 
promoter, and treatment with HDAC inhibitors leads to the inhibition of tumor-cell 
growth and an increase in both the acetylation of the promoter and gene expression. 
 It has been found that when the transcription factor Snail recruits HDAC1, HDAC2,and 
the co repressor complex mSin3A to the E-cadherin promoter, its expression is repressed. 
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 Down regulation or loss of function of E-cadherin has been implicated in the acquisition 
of invasive potential by carcinomas , and so the aberrant recruitment of HDACs to this 
promoter may have a crucial role in tumor invasion and metastasis. 
 Class I HDACs are involved in transcription-repression mediated by retinoblastoma (Rb) 
protein. The lost of HDAC2 function could induce hyperacetylation and re-expression of 
genes regulated by Rb and crucial functions in cell cycle regulation. 
                                                                     
2.3 HDAC1 GENE 
 HDAC1 belongs to class I HDACs having the catalytic domain on the N-terminus which 
forms the major part of the protein. 
  HDAC1 and HDAC2 remains inactive when they are produced by recombinant 
techniques, these cofactors are necessary for the activity of HDAC. 
 In vivo, HDAC1 and HDAC2 only display activity with in a complex of proteins. 
 Proteins necessary for modulating their deacetylase activity and for binding DNA are 
present in these complexes. Together with proteins they mediate the recruitment of 
HDACs to the promoters of genes. 
 Three protein complexes Sin3v, NuRD (nucleosome Remodelling and deacetylating) and 
Co-REST that have been characterized with both HDAC1 and HDAC2.  
 Both the Sin3 complex (named after its characteristic element mSin3A) and NuRD 
complex consist of a core complex that constitutes HDAC1, HDAC2, Rb-associated 
protein 48 (RbAp48, which binds histone H4 directly) and RbAp46.  
 The core complex cannot give maximum HDAC activity and needs cofactors 
additionally.  
 HDAC1 and HDAC2 can also bind directly to DNA binding proteins such as YY1 (Yin 
and Yang1, a cellular nuclear matrix regulatory protein), Rb binding protein-1 and Sp1 
apart from functioning through these complexes. 
 In addition to the regulation of HDAC1 and HDAC2 activity by the availability of co-
repressors, a second means of regulating activity is via post-translational modifications. 
  Both activity and complex-formation are regulated by phosphorylation. HDAC1and 
HDAC2 are phosphorylated at a low steady-state level in resting cells. 
12  
 
 Hyper Phosphorylation of HDAC1 and HDAC2 leads to a slight but significant increase 
in deacetylase activity and at the same time to disruption of complex-formation between 
HDAC1 and HDAC2. 
 When hypo phosphorylation of HDAC1 and HDAC2 occurs, the activity of HDAC1 and 
HDAC2 decreases, but complex-formation is increased. 
 Maintenance of HDAC activity at a certain optimal level is done by apparent 
contradictory consequences of Phosphorylation. Mutational analysis of HDAC1 shows 
that Ser
421
 and Ser
423
 are crucial Phosphorylation sites; when they are mutated,complex-
formation is hampered and HDAC activity is decreased (Fig:11) 
 Although HDAC1 has been mostly studied in the context of cancer, recent evidence 
strongly suggests that it plays critical roles in cellular senescence, aging of the liver, 
myelination, and adult neuro genesis. (Annemieke, et al., 2003) 
2.4 Over expression of HDAC1 proliferates breast cancer by negative regulation of    
estrogen receptor α. 
 The interaction between17 β-estradiol and estrogen receptor alpha (ER-α) plays an 
important role in breast carcinogenesis and breast cancer treatment.  
 ER- α is a critical growth regulatory gene in breast cancer and its expression level is 
tightly linked to the prognosis and treatment outcomes of breast cancer patients. 
  For breast cancer progression, loss of ER-α expression in breast epithelial cells is 
critical. 
 The molecular mechanisms for this loss, are still poorly deﬁned. 
  Alteration of chromatin assembly and tumorigenesis are due to histone deacetylases 
(HDACs) implication. 
 It has been showed that histone deacetylase1 (HDAC1) interacts with ER-α in vitro 
and in vivo and suppresses ER-α transcription activity. 
 The interaction of HDAC1 with ER-α was mediated by the AF-2 and DBD domains 
of ER-α.  
 An endogenous interaction of HDAC1 with ER-α has been observed in breast cancer 
cells, which was decreased in the presence of estrogen. 
 A possible mechanism for the loss of ER-α in ER-negative breast cancers is cytosine 
methylation of the ER CpG island in the 5’ regulatory region of the gene.  
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 The ER gene CpG islands extensively methylated in ER–negative breast cancer cells 
and approximately 50% of unselected primary breast tumors remain unmethylated in 
normal breast tissue and in many ER-positive tumors and ER-positive breast cancer 
cell lines.   
 Interestingly, over expression of HDAC1 instable transfected MCF-7 clones induced 
loss of ER-α and signiﬁcantly increased cell proliferation and colony formation, as 
compared to the control MCF-7 cells, whereas treatment of stable MCF-7 clones with 
the HDAC speciﬁc inhibitor Trychostatin (TSA) induced re-expression of ER-α 
mRNAand protein. 
 HDAC1 affects breast cancer progression by promoting cellular proliferation in 
association with a reduction in both ER-α protein expression and transcriptional 
activity.  
 HDAC1 may be a potential target for therapeutic intervention in the treatment of a 
subset of ER-negative breast cancers (Kawai, Li, and Avraham et al.,2003 ). 
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3. OBJECTIVE 
 
To clarify the role of HDACs in the aberrant promoter hypoacetylation of TSGs in 
various human cancers, the expression levels of a number of HDACs in cancer tissues were 
examined. The expressions of the HDAC1 gene were examined, since these enzymes have 
a reported role in deacetylation status integrity and have been implicated in the 
transcriptional regulatory changes of human cancer.  
So our main objective was “Comparative Analysis of histone deacetylase1 Expression 
in Normal and Human Cancer Tissues”. 
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        4. MATERIALS AND METHODS 
The Human blood was collected from CWS Hospital, Rourkela as normal human 
tissue and gall bladder and lymph node cancer tissues were collected from Calcutta 
National Medical College, Kolkata. 
(A) Total RNA Isolation: 
Reagents and Buffers 
 TRIzol Reagents (Sigma), 
 Choloroform, 
 Isopropanol, 
 Ethanol (70%), 
 Denaturation Buffer 
 50 % deionized formamide, 
 2.2 M formaldehyde, 
 MOPS buffer (pH 7.0), 
 6.6 % glycerol, 
 0.5 % bromphenol,  
 Ethidium Bromide (EtBr), 
 Agarose 
 
           Protocol: 
 50-100 mg of tissue in a 2 ml tube with 1 ml TRIzol was transferred. 
 Homogenized for 60 sec in the polytron. 
 200 l chloroform was added. 
 It was mixed by inverting the tube for 15 sec. 
 Incubated for 3 min at room temperature. 
 Centrifuged at 12.000 g for 15 min. 
 The aqueous phase was transferred into a fresh Eppendorf tube. 
 500 l isopropanol was added. 
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 Centrifuged at max. 12.000 g for 10 min in the cold room. 
 The pellet was washed with 500 l 70 % ethanol. 
 Centrifuged at max. 7.500 g for 5 min in the cold room. 
 The pellet was dried on air for 10 min. 
 Then the pellet was dissolved in 50-100 l DEPC-H2O. 
 Incubated for 10 min at 60 C. 
 Spectrophotometric reading was taken. 
 Analysed the RNA on a MOPS gel: 
 1-3 g RNA was dissolved in 11 l denaturation buffer. 
 1 l Ethidium bromide (1mg/ml) was added and denatured at 65 C for 15 min 
 1 % agarose gel was loaded in MOPS buffer plus 5 % formaldehyde. 
 The gel was run at 40 V for 4 h. 
 
(B) cDNA Synthesis (rt-PCR): 
     Regents and Buffer 
 5X First Strand Buffer 
 10mM dNTP Set 
 0.1M DTT 
 Random Primers 
 RNase OUT Ribonuclease Inhibitor 
 Super Script II RNase H- Reverse Transcriptase 
          Protocol: 
 8µl of total RNA were taken. 
 Then 3 μl Random Primers was added. 
 1 μl dNTP mix was added. 
 Then vortex and spin downed tube. 
 Incubated at 65°C for 5 min. 
 Placed tube on ice. 
 4 μl 5X Buffer, 2 μl DTT and 1μl RNAase Out were added. 
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 Then vortex and spin downed tube. 
 Incubated at 42°C for 1 min. 
 1μl SuperScript II RNase H- Reverse Transcriptase was added. 
 Incubated at 42°C for 60 min. 
 Incubated at 70°C for 15 min. 
 180 μl of molecular grade water was added. 
 Nanodrop 1000 was used to measure concentration. Set sample typesetting to Other 
Sample and the constant to 33. 
 Stored at -80°C. 
 
   Gene specific PCR               
Used Primers:- 
Gene Forward Primer Reverse Primer 
HDAC1 5’-TTCAAGCCGGTCATGTCCAAAG-3  5’-TTTGATCTTCTCCAGGTACTC-3'          
β-Actin 5`- TCTACAATGAGCTGCGTGTG-3` 5`- ATCTCCTTCTGCATCCTGTC-3` 
 
                                                                                                                          (Patra et al., 2001.) 
PCR mixture:-(Total 25µl): 
 0.2 µM dNTP- 0.5µl 
 1.5 mM MgCl2- 1.5µl 
 1x PCR Buffer- 2.5µl 
 TaqPolymerase (5U/µl) 
 
PCR conditions: -   94°C for 1min, 
                                           26 cycles at 94°C for 20s, 
                                           57°C for 20s, and 
                                           72°C, Followed by an extension step at 72°C for 5min 
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5. RESULTS AND DISCUSSIONS 
RNA EXTRACTION FROM NORMAL TISSUE (BLOOD): 
Product Conc
n
.
 
(µg/ml) Purity 
260/280 260/230 
Total RNA 598.32 1.45 0.96 
 
Spectrophotometer results of total RNA from blood tissue 
                                                                                    
(Total RNA in 1% agarose gel)                                                       
Table 1. Spectrophotometer results of gene specific amplification product from blood 
Gene Conc
n
.
 
(µg/ml) Purity 
260/280 260/230 
β-actin         1564.12 1.25 1.13 
HDAC1          1696.36 0.96 0.83 
                                    
               
(Gene specific PCR amplification in blood) 
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RNA EXTRACTION FROM CANCEROUS TISSUE: 
Table 2. Spectrophotometer results of RNA concentration from Cancer. 
Tissue Conc
n
.
 
(µg/ml) Purity 
260/280 260/230 
Lymph Node Cancer 917.51 1.61 1.02 
 
Spectrophotometer results of total RNA from cancerous tissue 
 
                            Lane 1:lymph node cancer 
 
 
                                                                                                       
                                                                                                  
                                                      (Total RNA from denaturation gel) 
GENE SPECIFIC PCR AMPLIFICATION: 
Table 3. Spectrophotometer results of gene specific amplification product from lymph node 
cancer tissue 
Gene Conc
n
.
 
(µg/ml) Purity 
260/280 260/230 
              β-actin 1998.34 1.331 1.015 
HDAC1 1746.0        0.9346 0.1426 
1 2 
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Expression of HDAC in lymph node cancer: 
 
  
Lane 1 shows the expression of β-actin which performs as a house keeping gene and is 
constitutively expressed. By taking the DNA ladder (lane 7) as a standard the expression of 
HDAC1(lane 2) has been seen and we can see the expression of HDAC1 suggesting an role in 
causing lymph node cancer. 
 
 
1       2       3      4     5      6      7    8  
888888  
Lane 1: β-actin 
Lane 2: HDAC1 gene 
Lane 7: DNA ladder 
(1.5 kb) 
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After isolation the total RNA from normal blood and Cancerous tissue, we checked their 
concentration by taking its OD in spectrophotometer, in case of Lymph node cancer the 
concentration was found to be 917.51µg/ml, which was comparatively less to the other samples 
reading. Because it was took a lot of time to processing after collecting the sample and also 
cDNA was not synthesize from the total RNA by rt-PCR method due to some unsuitable 
condition. 
The concentration of the HDAC1 in the normal tissue is 1696.36 µg/ml, and in the lymph 
node cancer tissue it is 1746.0µg/ml. The activity of the enzyme has been quietly increased in the 
cancer tissue but as the β-Actin has been maintained as it is only helping in the housekeeping 
function. 
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6. DISCUSSIONS 
HDACs, appears to be the key enzymes in the regulation of gene expression. HDAC function 
seems to be regulated by its intrinsic features, abundance, cellular compartmentalization and 
association with co-factors. Despite extensive investigation of the biological functions of 
HDACs, a little is known about the expression status of HDACs in lymph node metastasis. Our 
results clearly showed the increased expression of HDAC1 in lymph node cancer tissue at 
transcriptional level.So,the increased expression of HDAC1 may causing the down regulation of 
tumor suppressor gene(TSG),such as p
53
. These data implies that HDAC1 expression may cause 
histone hypoacetylation leading to the silencing of several tumor suppressor genes in lymph node 
cancer.  
Now, we know that after methylation of the gene the MeCpG binding proteins will bind 
the gene which allows the HDACs to bind in their position to de-acetylate the gene that helps in 
the heterochromatin formation. If we will observe the results we got from the comparison of the 
normal tissue with the cancer tissue, the expression of the methylating enzymes mainly DNMT1 
has been suppressed. From this, we can conclude that the over expression of the HDACs in the 
cell is leading to the suppression of the DNMTs that finally lay lead to the tumor formation that 
paves a way to the cancer development. 
     In conclusion, the present study clearly demonstrated that HDAC1 showed increased 
expression in lymph node cancer and probably plays a significant role in lymph node cancer. 
Further studies: 
Further studies using large number of samples and covering other HDACs are needed to identify 
the cell cycle regulators affected by HDACs and to asses the feasibility in lymph node cancer by 
using HDACs as prognostic factor. HDAC inhibitor can be used with less cellular toxicity as a 
cancer therapeutic agent. 
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